Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Debt: 2021-2024

Historic Total Debt for Roivant Sciences (ROIV) over the last 4 years, with Mar 2024 value amounting to $200.7 million.

  • Roivant Sciences' Total Debt fell 1.62% to $203.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $203.5 million, marking a year-over-year decrease of 1.62%. This contributed to the annual value of $200.7 million for FY2024, which is 0.01% up from last year.
  • Per Roivant Sciences' latest filing, its Total Debt stood at $200.7 million for FY2024, which was down 7.79% from $217.7 million recorded in FY2023.
  • In the past 5 years, Roivant Sciences' Total Debt registered a high of $217.7 million during FY2023, and its lowest value of $32.6 million during FY2022.
  • Its 3-year average for Total Debt is $169.4 million, with a median of $200.7 million in 2023.
  • As far as peak fluctuations go, Roivant Sciences' Total Debt tumbled by 80.84% in 2022, and later surged by 515.19% in 2023.
  • Over the past 4 years, Roivant Sciences' Total Debt (Yearly) stood at $170.3 million in 2021, then reached $204.0 million in 2021, then plummeted by 80.84% to $32.6 million in 2022, then fell by 4.39% to $195.1 million in 2022, then spiked by 515.19% to $200.7 million in 2023, then grew by 11.59% to $217.7 million in 2023, then rose by 0.01% to $200.7 million in 2024.